Study: When to treat hypertension and intensify treatment
the ONA take:
According to a new study published in the British Medical Journal, researchers at Brigham and Women's Hospital in Boston, Massachusetts, have determined the precise blood pressure level and time points at which intervening with antihypertensives was associated with a decreased risk of death.
Researchers found that that patients with systolic blood pressures between 130 and 150 had no increase in risk, but those with systolic blood pressures above 150 had progressively greater risk of acute cardiovascular event, such as stroke or myocardial infarction, or death.
In addition, they found that delaying intensification of treatment, which was defined as increasing the dosage of antihypertensives or adding new antihypertensives when blood pressure levels increase, by more than 1.4 months was associated with increased risk of cardiovascular event or death.
The team also found that patients who received a blood pressure reassessment more than 2.7 months after treatment intensification had an increased risk of death.
The findings suggest the importance of avoiding treatment delays and follow-up delays for patients with hypertension, particularly those with systolic blood pressure levels greater than 150.
Precise blood pressure level and time points at which intervening with antihypertensives was associated with a decreased risk of death.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|